FOXP1 and diffuse large B-cell lymphoma: These data indicate that the FOXP1 oncogene and the tumor suppressor CDKNA2 implicated in EBV(−) DLBCL, do not play a role in the pathogenesis of EBV(+) PT-DLBCL.